Quick Answer
LEMAITRE VASCULAR INC reported Cash and Equivalents of $28.24 million for fiscal year 2025.
LEMAITRE VASCULAR INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $28.24M | +10.3% |
| 2024 | $25.61M | +5.5% |
| 2023 | $24.27M | +26.8% |
| 2022 | $19.13M | +38.1% |
| 2021 | $13.86M | -48.2% |
| 2020 | $26.76M | +127.1% |
| 2019 | $11.79M | -55.2% |
| 2018 | $26.32M | +37.8% |
| 2017 | $19.10M | -21.4% |
| 2016 | $24.29M | -11.5% |
| 2015 | $27.45M | +46.9% |
| 2014 | $18.69M | +27.1% |
| 2013 | $14.71M | -10.6% |
| 2012 | $16.45M | -18.3% |
| 2011 | $20.13M | -11.0% |
| 2010 | $22.61M | -2.5% |
| 2009 | $23.19M | +45.9% |
| 2008 | $15.89M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $25.49M | +21.4% | -6.2% |
| June 30, 2025 | $27.18M | +22.0% | +7.2% |
| March 31, 2025 | $25.34M | -4.7% | -1.1% |
| December 31, 2024 | $25.61M | +5.5% | +21.9% |
| September 30, 2024 | $21.00M | +16.3% | -5.7% |
| June 30, 2024 | $22.27M | +14.3% | -16.3% |
| March 31, 2024 | $26.59M | +59.5% | +9.6% |
| December 31, 2023 | $24.27M | +26.8% | +34.4% |
- LEMAITRE VASCULAR INC showed an increase of +10.3% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, LEMAITRE VASCULAR INC’s cash and equivalents has grown by 77.7% (from $15.89 million to $28.24 million).
- The most recent figure is from LEMAITRE VASCULAR INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: